Dr. Corinna Fiorotti brings two decades of drug development experience in large pharma/biotech which spans from research through clinical development, with expertise in building and executing strategies for bioanalytical development. Furthermore, Dr. Fiorotti additionally possesses a deeply integrated understanding of the CRO industry from both the scientific and business perspectives as she has held senior level roles that combine the two and built an outstanding track record of business success. Dr. Fiorotti holds a Ph.D. in Immunology and Microbiology and completed a post-doctoral fellowship in Molecular Biology at Harvard Medical School where her work was featured as a cover story in the journal Nature. Dr. Fiorotti’s depth and breadth of knowledge in immunogenicity and bioanalytical assays covers a wide range of disease areas and therapeutic modalities including protein therapeutics, and cell and gene therapy. She is an established global expert in ADA, PK and cell-based assays in support of both pre-clinical and clinical development and is highly sought-after as an invited speaker at bioanalytical focused meetings. Dr. Fiorotti has an exceptional track record working collaboratively with project teams to identify critical questions/decision points and deliver strategies to address them, leading to efficient prosecution of client’s drug development programs.